Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial - Concepedia

Concepedia

Publication | Open Access

Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial

DOI Full Paper Access

47

Citations

19

References

2022

Year

Sophie Cousin, Coralie Cantarel, Jean‐Philippe Guégan, Thibault Mazard, Carlos Gomez‐Roca, Jean‐Philippe Metges, Carine Bellera, Antoine Adenis, Iphigénie Korakis, Pierre-Guillaume Poureau,

European Journal of Cancer

Phase Ii TrialGastrointestinal OncologyMedicineBiliary CancerClinical TrialsBiliary Tract CancerRegorafenib–avelumab CombinationSurgeryPharmacotherapyCancer TreatmentOncologyRadiation OncologyCancer ResearchHealth Sciences

References

	Year	Citations

Page 1

Page 1